Automatically produced note
LABORATORIO LIBRA: 99.4% of the HYDROXYUREA market in 2026
The company secured almost all of the purchases for this medication in the year, totaling $ 5.7 billion. Three companies sold in this category.
What was measured
LABORATORIO LIBRA SOCIEDAD ANONIMA was awarded purchases for $ 5.7 billion in the HYDROXYUREA (TABLETS) category during 2026. The total for the category in the year was $ 5.8 billion. The company's participation in this category was 99.4%. Three companies sold this medication in the period.
The measured block
| Measured | Value | Where it comes from |
|---|---|---|
| Adjudicado a LABORATORIO LIBRA SOCIEDAD ANONIMA en el rubro, 2026 | $ 5,7 mil millones | releases.amount.primaryAmount por awards.items.classification.id |
| Total del rubro en el año | $ 5,8 mil millones | suma de todos los proveedores del mismo código; una compra con más de un adjudicatario suma a cada uno, lo que subestima la participación y nunca la exagera |
| Participación de la empresa | 99,4% | cociente entre las dos filas anteriores |
| Empresas que vendieron el rubro | 3 | proveedores distintos con adjudicación en el código |
| Código de catálogo | 16844 | awards.items.classification.id (catálogo SICE) |
Reproduce this measurement:npx tsx src/jobs/daily-investigation.ts --lane=concentracion-rubro --dry-run
Context
The category corresponds to catalog code 16844 from SICE. It refers to HYDROXYUREA in tablets. The measured period is from January 1 to August 18, 2026.
The rule it puts in play
Concentrating a category is not in itself an infraction: it may reflect a market with only one capable supplier. The competition defense law does prohibit agreeing or coordinating offers between competitors, and that is a different conduct that this measurement does not observe.
What is missing to say more
To evaluate the concentration of the HYDROXYUREA (TABLETS) market, information on the number of suppliers that participated in the tenders and the number of offers submitted would be needed. This would allow determining whether LABORATORIO LIBRA SOCIEDAD ANONIMA's high participation is due to a lack of competition or its ability to offer better conditions.
Who should answer
The Commission for the Promotion and Defense of Competition must respond whether the observed concentration in the HYDROXYUREA (TABLETS) category corresponds to market dynamics or if there are indications of anti-competitive practices.
Tell it where you can be protected
We publish what is in the open data. What isn't — the file, the message, what was said in the meeting — goes to Uruguay Leaks, the anonymous inbox run by la diaria, PODER and DATA Uruguay. The message is written for you: copy it, add what you know and paste it into their form.
Do not send it from your work computer or work email. Uruguay Leaks protects the submission, not the machine you send it from.
Uruguay Leaks is a project by la diaria, PODER and DATA Uruguay. We are not affiliated with them and receive no copy of what you send.